© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
LISTE
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study https://www.bmj.com/content/373/bmj.n1114
European Medicines Agency. Signal assessment report on embolic and thrombotic events (SMQ) with COVID-19 Vaccine (ChAdOx1-S [recombinant])-Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (Other viral vaccines). 2021.
Global Vaccine Data Network. Observed vs. expected analyses of COVID-19 vaccine adverse events of special interest study protocol. Version 1.4. Auckland (NZ): Global Vaccine Data Network; 2022. Available from: https://www.globalvaccinedatanetwork.org/ourwork/global-covid-vaccine-safety-gcovs
Observed-over-Expected analysis as additional method for pharmacovigilance signal detection in large-scaled spontaneous adverse event reporting https://onlinelibrary.wiley.com/doi/10.1002/pds.5610





